Cargando…

Immunogenicity of the nanovaccine containing intimin recombinant protein in the BALB/c mice

PURPOSE: Escherichia coli O157:H7 is one of the most important pathogens which create hemorrhagic colitis and hemolytic uremic syndrome in human. It is one of the most prevalent causes of diarrhea leading to death of many people every year. The first diagnosed gene in the locus of enterocyte effacem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hosseini, Zahra Sadat, Amani, Jafar, Baghbani Arani, Fahimeh, Nazarian, Shahram, Motamedi, Mohammad Javad, Shafighian, Fatemeh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Vaccine Society 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5795045/ https://www.ncbi.nlm.nih.gov/pubmed/29399580 http://dx.doi.org/10.7774/cevr.2018.7.1.51

Ejemplares similares

Preparation of chitosan nanoparticle containing recombinant StxB antigen of EHEC and evaluation its immunogenicity in BALB/c mice
por: Almasian, Pegah, et al.
Publicado: (2018)

Recombinant expression of SARS-CoV-2 receptor binding domain (RBD) in Escherichia coli and its immunogenicity in mice
por: Rahbar, Zahra, et al.
Publicado: (2022)

Nanovaccine for leishmaniasis: preparation of chitosan nanoparticles containing Leishmania superoxide dismutase and evaluation of its immunogenicity in BALB/c mice
por: Danesh-Bahreini, Mohammad Ali, et al.
Publicado: (2011)

Immunogenic evaluation of chimeric recombinant protein against ETEC, EHEC and Shigella
por: Khalouie, Farzane, et al.
Publicado: (2017)

Immunogenicity of the Multi-Epitopic Recombinant Glycoproteins of Newcastle Disease Virus: Implications for the Serodiagnosis Applications
por: Motamedi, Mohammad Javad, et al.
Publicado: (2018)

Design of a chitosan-based nano vaccine against epsilon toxin of Clostridium perfringens type D and evaluation of its immunogenicity in BALB/c mice
por: Poorhassan, Farnaz, et al.
Publicado: (2021)

Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers
por: Nooraei, Saghi, et al.
Publicado: (2021)

Antigenicity and immunogenicity of SARS-CoV-2 surface glycoprotein fragment in CHO cells
por: Karimi, Sahar, et al.
Publicado: (2023)

Immunogenicity of inactivated Escherichia coli O157:H7 with Stx2B microparticle in mice
por: Arshadi, Nasim, et al.
Publicado: (2022)

Immunogenic Potency of Formalin and Heat Inactivated E. coli O157:H7 in Mouse Model Administered by Different Routes
por: Arshadi, Nasim, et al.
Publicado: (2020)

Evaluation of Metastasis Suppressor Genes Expression and In Vitro Anti-Cancer Effects of Zinc Oxide Nanoparticles in Human Breast Cancer Cell Lines MCF-7 and T47D
por: Shandiz, Seyed Ataollah Sadat, et al.
Publicado: (2021)

Immunogenicity of Cork and Loop Domains of Recombinant Baumannii acinetobactin Utilization Protein in Murine Model
por: Esmaeilkhani, Hamid, et al.
Publicado: (2019)

Imatinib induces up-regulation of NM23, a metastasis suppressor gene, in human Hepatocarcinoma (HepG2) Cell Line
por: Keshavarz-Pakseresht, Behta, et al.
Publicado: (2017)

EspA-Intimin chimeric protein, a candidate vaccine against Escherichia coli O157:H7
por: Rad, Hamid Sedighian, et al.
Publicado: (2013)

Preparation of chitosan nanoparticle containing recombinant CD44v antigen and evaluation of its immunization capacity against breast cancer in BALB/c mice
por: Gheybi, Elaheh, et al.
Publicado: (2023)

Evaluation of Immunogenic Effect of Toxoplasma gondii Recombinant SAG-1 Antigen with Propranolol as Adjuvant in BALB/c Mice
por: Abasi, Esmaeil, et al.
Publicado: (2019)

Preclinical study of formulated recombinant nucleocapsid protein, the receptor binding domain of the spike protein, and truncated spike (S1) protein as vaccine candidates against COVID-19 in animal models
por: Nazarian, Shahram, et al.
Publicado: (2022)

Immunogenicity and protection effects of cationic liposome containing imiquimod adjuvant on leishmaniasis in BALB/c mice
por: Mehravaran, Ahmad, et al.
Publicado: (2019)

A bi-adjuvant nanovaccine that potentiates immunogenicity of neoantigen for combination immunotherapy of colorectal cancer
por: Ni, Qianqian, et al.
Publicado: (2020)

Allele- and Tir-Independent Functions of Intimin in Diverse Animal Infection Models
por: Mallick, Emily M., et al.
Publicado: (2012)

The Bacterial Intimins and Invasins: A Large and Novel Family of Secreted Proteins
por: Tsai, Jennifer C., et al.
Publicado: (2010)

Crystal Structure of EHEC Intimin: Insights into the Complementarity between EPEC and EHEC
por: Yi, Yong, et al.
Publicado: (2010)

The EHEC-host interactome reveals novel targets for the translocated intimin receptor
por: Blasche, Sonja, et al.
Publicado: (2014)

Benefits of an Immunogenic Personalized Neoantigen Nanovaccine in Patients with High‐Risk Gastric/Gastroesophageal Junction Cancer
por: Liu, Qin, et al.
Publicado: (2022)

Induction of Immunogenic Response in BALB/c Mice by Live and Killed Form of Recombinant Lactococcus lactis Displaying EG95 of Echinococcus granulosus
por: Ebrahimzadeh, Fatemeh, et al.
Publicado: (2021)

Molecular identification of Phlebotomus kandelakii apyrase and assessment of the immunogenicity of its recombinant protein in BALB/c mice
por: Fayaz, Shima, et al.
Publicado: (2023)

An in silico Design, Expression and Purification of a Chimeric Protein as an Immunogen Candidate Consisting of IpaD, StxB, and TolC Proteins from Shigella spp.
por: Fathi, Javad, et al.
Publicado: (2022)

Immunogenicity of a Trivalent Human Papillomavirus L1 DNA-Encapsidated, Non-Replicable Baculovirus Nanovaccine
por: Cho, Hansam, et al.
Publicado: (2014)

Amphiphilic polyanhydride-based recombinant MUC4β-nanovaccine activates dendritic cells
por: Banerjee, Kasturi, et al.
Publicado: (2019)

Serotypes, intimin variants and other virulence factors of eae positive Escherichia coli strains isolated from healthy cattle in Switzerland. Identification of a new intimin variant gene (eae-η2)
por: Blanco, Miguel, et al.
Publicado: (2005)

Advancements in prophylactic and therapeutic nanovaccines
por: Bhardwaj, Prateek, et al.
Publicado: (2020)

Pulmonary delivery of mucosal nanovaccines
por: Tang, Wei, et al.
Publicado: (2021)

Self-adjuvanting cancer nanovaccines
por: Liao, Zhiyun, et al.
Publicado: (2022)

Addressing Nanovaccine Strategies for Tilapia
por: Thompson, Kim D., et al.
Publicado: (2023)

Semisynthetic Pneumococcal Glycoconjugate Nanovaccine
por: Prasanna, Maruthi, et al.
Publicado: (2023)

Protection of rabbits against enteropathogenic Escherichia coli (EPEC) using an intimin null mutant
por: Stakenborg, Tim, et al.
Publicado: (2006)

Functional studies of intimin in vivo and ex vivo: implications for host specificity and tissue tropism
por: Mundy, Rosanna, et al.
Publicado: (2007)

Detection of E. coli O157:H7 and Shigella dysenteriae toxins in clinical samples by PCR-ELISA
por: Amani, Jafar, et al.
Publicado: (2015)

Immunogenicity of SARS inactivated vaccine in BALB/c mice
por: Xiong, Sheng, et al.
Publicado: (2004)

Immunogenicity of recombinant Lactobacillus plantarum NC8 expressing goose parvovirus VP2 gene in BALB/c mice
por: Liu, Yu-Ying, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_nfok1vg647ndih18a3og3t2oin